{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:21:54Z","timestamp":1793294514161,"version":"4.5.0"},"reference-count":103,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T00:00:00Z","timestamp":1296691200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p>Bisphosphonates are used in the treatment of hypercalcemia of malignancy, skeletal complications associated with metastastic bone disease, Paget's disease, and osteoporosis. Osteonecrosis of the jaw (ONJ) is a recently described clinical condition that has been associated with the use of nitrogen\u2010containing bisphosphonates. Reports describing this entity first appeared in the literature in 2003. While there have been significant numbers of case reports and a limited number of retrospective and prospective studies examining risk factors associated with ONJ, the pathophysiology of this condition remains elusive. In this review, we explore proposed mechanisms underlying ONJ development and identify potential areas for future investigation.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2010.05835.x","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T21:57:51Z","timestamp":1296770271000},"page":"62-79","source":"Crossref","is-referenced-by-count":141,"title":["Potential pathophysiological mechanisms in osteonecrosis of the jaw"],"prefix":"10.1111","volume":"1218","author":[{"given":"Regina","family":"Landesberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Marolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Vunjak\u2010Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Kousteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikala","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,3]]},"reference":[{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-6-481"},{"key":"e_1_2_13_3_2","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double\u2010blind, comparative trial","volume":"7","author":"Rosen L.S.","year":"2001","journal-title":"Cancer J."},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900605"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.99.132"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00328-8"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.11.003"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.01.009"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0707onj"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.1269"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.06.004"},{"key":"e_1_2_13_16_2","first-page":"385","article-title":"Bisphosphonate\u2010related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons","volume":"28","author":"Toshiyki T.","year":"2010","journal-title":"J. Bone Miner. Metab"},{"key":"e_1_2_13_17_2","volume-title":"Br. J. Oral Maxillofac. Surg.","author":"Patel V.","year":"2010"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4477.2009.00213.x"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.04.015"},{"key":"e_1_2_13_20_2","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo M.D.","year":"2005","journal-title":"J. Can. Dent. Assoc."},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0516-2"},{"key":"e_1_2_13_22_2","volume-title":"Int. J. Oral Maxillofac. Surg.","author":"Kos M.","year":"2010"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2007.12.001"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/648075"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.54.1.413"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070609"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.04.198"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600830521"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.5.784"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00658.x"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00589-0"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422087"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200306000-00006"},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.04.022"},{"key":"e_1_2_13_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.01.026"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.10.788"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.04.196"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00531-5"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555853"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1612-7"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1990.tb00750.x"},{"key":"e_1_2_13_43_2","first-page":"239","article-title":"Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy\u2010associated hypercalcemia","volume":"35","author":"Usui T.","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"e_1_2_13_44_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.16.1.191"},{"key":"e_1_2_13_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01654"},{"key":"e_1_2_13_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(03)00580-5"},{"key":"e_1_2_13_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2005.01.025"},{"key":"e_1_2_13_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6"},{"key":"e_1_2_13_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(199701)64:1<128::AID-JCB15>3.0.CO;2-H"},{"key":"e_1_2_13_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2006.01.021"},{"key":"e_1_2_13_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2007.01402.x"},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.10.1219"},{"key":"e_1_2_13_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07739.x"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.10.010"},{"key":"e_1_2_13_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2009.08.030"},{"key":"e_1_2_13_56_2","first-page":"237","article-title":"Effect of pamidronate on bone blood flow in oophorectomized rats","volume":"47","author":"Kapitola J.","year":"1998","journal-title":"Physiol. Res."},{"key":"e_1_2_13_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-2391(83)90294-X"},{"key":"e_1_2_13_58_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035295"},{"key":"e_1_2_13_59_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308114200"},{"key":"e_1_2_13_60_2","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone\u2010stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier P.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_13_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.09.083"},{"key":"e_1_2_13_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02218-0"},{"key":"e_1_2_13_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07702.x"},{"key":"e_1_2_13_64_2","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini D.","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_13_65_2","first-page":"2893","article-title":"Zoledronic acid induces significant and long\u2010lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini D.","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_13_66_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0551"},{"key":"e_1_2_13_67_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.144"},{"key":"e_1_2_13_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0933-9"},{"key":"e_1_2_13_69_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32169"},{"key":"e_1_2_13_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67700-8"},{"key":"e_1_2_13_71_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2036"},{"key":"e_1_2_13_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6413.267"},{"key":"e_1_2_13_73_2","first-page":"150","article-title":"Osteonecrosis of bone associated with combination chemotherapy without corticosteroids","volume":"204","author":"Marymont J.V.","year":"1986","journal-title":"Clin. Orthopead. Rel. Res."},{"key":"e_1_2_13_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.2002.tb01178.x"},{"key":"e_1_2_13_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.moo.0000127829.34643.fd"},{"key":"e_1_2_13_76_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860601185917"},{"key":"e_1_2_13_77_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-033571"},{"key":"e_1_2_13_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl294"},{"key":"e_1_2_13_79_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090592"},{"key":"e_1_2_13_80_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0843"},{"key":"e_1_2_13_81_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021500"},{"key":"e_1_2_13_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02665.x"},{"key":"e_1_2_13_83_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301230"},{"key":"e_1_2_13_84_2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann V.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_13_85_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903043400914"},{"key":"e_1_2_13_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-198909000-00028"},{"key":"e_1_2_13_87_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00003086-199204000-00006","article-title":"Intravascular coagulation and osteonecrosis","volume":"277","author":"Jones J.P.","year":"1992","journal-title":"Clin. Orthop. Relat. Res."},{"key":"e_1_2_13_88_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205283262206"},{"key":"e_1_2_13_89_2","volume-title":"Arthritis and Allied Conditions: A Textbook of Rheumatology.","author":"Jones J.P.","year":"2001"},{"key":"e_1_2_13_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90132-3"},{"key":"e_1_2_13_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450212"},{"key":"e_1_2_13_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830480402"},{"key":"e_1_2_13_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199701000-00007"},{"key":"e_1_2_13_94_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0038-1651633","article-title":"Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?","volume":"69","author":"Glueck C.J.","year":"1993","journal-title":"Thromb. Haemost."},{"key":"e_1_2_13_95_2","first-page":"195","article-title":"Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor","volume":"71","author":"Glueck C.J.","year":"1994","journal-title":"Thromb. Haemost."},{"key":"e_1_2_13_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(96)80047-3"},{"key":"e_1_2_13_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-008-0148-0"},{"key":"e_1_2_13_98_2","volume-title":"Osteonecrosis Etiology, Diagnosis and Treatment","author":"Glueck C.J.F.R.","year":"1997"},{"key":"e_1_2_13_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.04.007"},{"key":"e_1_2_13_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj105"},{"key":"e_1_2_13_101_2","doi-asserted-by":"publisher","DOI":"10.1177\/172460080201700405"},{"key":"e_1_2_13_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65498-5"},{"key":"e_1_2_13_103_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.12.2094"},{"key":"e_1_2_13_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl045"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2010.05835.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2010.05835.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:30:16Z","timestamp":1697499016000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05835.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1749-6632.2010.05835.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05835.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}